Star Health & Allied Insurance Company Ltd is Rated Hold

Aug 24 2026 10:10 AM IST
share
Share Via
Star Health & Allied Insurance Company Ltd is rated 'Hold' by MarketsMojo. This rating was last updated on 20 March 2026, reflecting a shift from a previous 'Sell' grade. However, the analysis and financial metrics discussed here represent the stock's current position as of 24 August 2026, providing investors with the latest insights into its performance and outlook.
Star Health & Allied Insurance Company Ltd is Rated Hold

Understanding the Current Rating

The 'Hold' rating assigned to Star Health & Allied Insurance Company Ltd indicates a neutral stance for investors. It suggests that while the stock is not currently a strong buy, it also does not warrant a sell recommendation. This balanced view is based on a comprehensive evaluation of four key parameters: Quality, Valuation, Financial Trend, and Technicals. Each of these factors contributes to the overall assessment of the company's investment potential as of today.

Quality Assessment

As of 24 August 2026, Star Health & Allied Insurance exhibits an average quality grade. The company demonstrates strong long-term fundamental strength, particularly highlighted by a compound annual growth rate (CAGR) of 19.64% in operating profits. This robust profit growth underscores the firm's ability to generate earnings consistently over time. However, this strength is tempered by a concerning decline in net sales, which have contracted at an annual rate of -48.82%. This negative sales growth signals challenges in expanding the company's top line, which may impact future profitability if not addressed.

Valuation Considerations

The valuation of Star Health & Allied Insurance is currently classified as very expensive. The stock trades at a price-to-book (P/B) ratio of 4.5, significantly higher than its peers' average historical valuations. This premium pricing reflects investor expectations of continued growth and profitability. However, the elevated valuation also implies limited margin for error, as any slowdown in performance could lead to price corrections. The company's return on equity (ROE) stands at 11.1%, which, while respectable, does not fully justify the high valuation multiple. Additionally, the price-to-earnings-growth (PEG) ratio is 4, indicating that the stock's price growth is outpacing its earnings growth, a factor that investors should monitor closely.

Financial Trend and Recent Performance

Currently, the financial trend for Star Health & Allied Insurance is positive. The latest quarterly results for June 2026 reveal record figures, with net sales reaching ₹5,522.07 crores and profit before depreciation, interest, and taxes (PBDIT) hitting ₹749.21 crores. The operating profit margin relative to net sales also peaked at 13.57%, marking the highest level recorded by the company. These results demonstrate operational efficiency and effective cost management, contributing to improved profitability.

In terms of stock returns, the company has delivered strong market-beating performance. As of 24 August 2026, the stock has generated a 1-year return of 28.63%, significantly outperforming the broader BSE500 index, which returned approximately 1.34% over the same period. The year-to-date return stands at 25.71%, with a six-month gain of 25.44%, reflecting sustained investor confidence. Shorter-term returns show some volatility, with a 1-day decline of -1.08% and a 1-week drop of -2.05%, but a positive 3-month return of 9.35% indicates resilience.

Technical Outlook

The technical grade for Star Health & Allied Insurance is mildly bullish. This suggests that the stock's price action and momentum indicators are generally positive, supporting the current 'Hold' rating. Mild bullishness indicates potential for moderate upside, but also cautions investors to be mindful of short-term fluctuations. The stock's trading patterns and volume trends imply that while there is buying interest, it is not yet strong enough to warrant a more aggressive buy recommendation.

Institutional Interest and Market Position

Institutional investors hold a significant stake in Star Health & Allied Insurance, with 35.45% of shares owned by these entities. This level of institutional holding is a positive signal, as such investors typically possess greater resources and expertise to analyse company fundamentals. Their confidence can provide stability to the stock price and may indicate expectations of steady future performance.

Momentum just kicked in! This Small Cap from the Auto - Trucks sector entered our list with explosive short-term signals. Catch the wave while it's still building!

  • - Fresh momentum detected
  • - Explosive short-term signals
  • - Early wave positioning

Catch the Wave Now →

What the Hold Rating Means for Investors

For investors, the 'Hold' rating on Star Health & Allied Insurance suggests a cautious approach. The stock's strong operating profit growth and recent record quarterly results provide a solid foundation, but the very expensive valuation and declining net sales growth warrant prudence. Investors already holding the stock may consider maintaining their positions to benefit from ongoing profitability and market-beating returns, while new investors might wait for a more attractive entry point or clearer signs of sustained sales growth.

Sector and Market Context

Operating within the insurance sector, Star Health & Allied Insurance faces competitive pressures and regulatory dynamics that can influence growth prospects. The company's small-cap status means it may be more volatile than larger peers, but also offers potential for higher returns if it can capitalise on market opportunities. The current mildly bullish technical outlook and strong institutional backing provide some reassurance amid sector uncertainties.

Summary

In summary, Star Health & Allied Insurance Company Ltd's 'Hold' rating reflects a balanced view of its current fundamentals and market position as of 24 August 2026. The company boasts strong operating profit growth and recent record financial results, yet faces challenges with net sales contraction and a high valuation multiple. The mildly bullish technical indicators and significant institutional ownership add further nuance to the investment case. Investors should weigh these factors carefully, recognising that the stock offers potential rewards alongside notable risks in the current market environment.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News